ERBB2 and invasive ductal breast carcinoma: A core needle biopsy confirmed human epidermal growth factor receptor 2 (HER2)-positive, lymphocyte-poor invasive ductal carcinoma, Nottingham Grade III, with a high Ki-67 index and extensive necrosis.